CONTACT
DIAGNOSTICS
ABOUT ABBOTT
i-STAT Registration
i-STAT Login
CUSTOMER HOME
PARTNERS HOME
DISTRIBUTION HOME
EMPLOYEES HOME
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account
United States

Global Point of Care

Make Every Minute Count

Afinion CRP point of care testing helps to make the most of every consultation with the patient.

Rapid and accurate decision-making helps improve the quality of conversation between doctor and patient, facilitating more effective treatment discussions in minutes for pneumonia and other respiratory infections.

Contact Us

Make Every Consultation Count

Antimicrobial resistance is a serious healthcare and economic problem, which could affect our ability to defend ourselves from infectious disease. Viral respiratory tract infections (RTIs) are one of the most common reasons for unnecessary antibiotic prescribing by healthcare professionals (HCPs) and patient expectations place additional pressure to prescribe antibiotics, even when diagnosis is uncertain.1-3

Point-of-care CRP testing helps to make the most of every consultation with the patient. A collaborative assessment by EUnetHTA concluded that the use of CRP POCT leads to reduced antibiotic prescribing both at consultation and up to 28 days follow-up.4 CRP POCT facilitates effective communication with patients about self-management and antibiotic prescribing.5-7

CRP POCT can reduce antibiotic prescribing by up to 42%,1,4,8-14 combining CRP POCT with enhanced communication skills of GPs have been shown to result in an even higher relative reduction of > 60%.8,11

90% of RTIs are caused by a virus, meaning antibiotics are unlikely to have any clinical benefit for these patients.15 

Contact us for More information about our Afinion products

-

Clinical Confidence in Minutes

The Afinion CRP assay is a simple fingerstick test. Make every moment during the patient consultation matter by quickly and easily determining your patients’ CRP level.

  • From drop to decision in just 3 minutes
  • Easy-to-use all-in-one cartridge with no pre-analytical steps
  • Minimally invasive for the patient, 2.5 μL fingerstick sampling
  • Excellent agreement with laboratory methods13, 17-21
  • No user calibration necessary
Afinion CRP
Download Brochure
To find out more about how Afinion CRP can transform your consultations

Download our brochure and contact a member of our team today!

Download Brochure

To always find the latest information about the Point of Care Testing and get CPD | CME Accreditation, register at My POC Academy website using the link below:

mypocacademy

References

  1. Aabenhus et al. Cochrane Database of Systematic Reviews 2014;11:1-70.
  2. Stanton et al. Br J Gen Pract 2010;60(581):e466-75. 
  3. Longitude survey 2014: https://www.nesta.org.uk/press-release/benefit-of-the-doubt-is-the-basis-for-prescribing-antibiotics-finds-longitude-survey/. Downloaded Oct. 2021.
  4. O’Brien et al. EUnetHTA Project ID: OTCA012. 2019
  5. Wood F et al. Family Practice 2011; 28:661–669.
  6. Butler CC et al. Scandinavian Journal of Primary Health Care 2008; 26: 17-21.
  7. Huddy JR et al. BMJ Open 2016;6: e009959.
  8. Cals et al. BMJ 2009; 338(51):137.
  9. Cals et al. The Annals of Family Medicine 2010;8(2):124-133.
  10. Andreeva et al. BMC Family Practice 2014;15(1):80.
  11. Little et al. The Lancet 2013;382(9899):1175-1182
  12. Butler et al. N Engl J Med 2019;381(2):111-120.
  13. Verbakel et al. BMJ Open 2019;9:e025036.
  14. Cooke J et al. BMJ Open Resp Res 2020;7:e000624.
  15. Bjerrum et al. BioMed Central Family Practice 2010; 11:29.
  16. WHO. 18. Nov. 2020. Preventing the COVID-19 pandemic from causing an antibiotic resistance catastrophe. https://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/news/news/2020/11/preventing-the-covid-19-pandemic-from-causing-an-antibiotic-resistance-catastrophe
  17. Hughes A, et al. Clinical Pharmacist 2016 Oct.
  18. Ivaska L et al. PLOS ONE 2015;10(6):e0129920.
  19. Brouwer N, et al. Clin Chim Acta 2015; 15(439):195-201.
  20. Minnaard MC et al. Scand J Clin Lab Invest 2013;73(8):627-34.
  21. Bukve T, et al. Clin Chem 2016;62(11):1474-1481.
  22. Minnaard MC et al. Scandinavian Journal of Clinical& Laboratory Investigation 2015; 75: 291–295.
  23. CDC. 27. Oct. 2020. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease; 
  24. Luo et al. medRxiv preprint 2020; 
  25. Wang et al. Open Forum Infect Dis 2020; 
  26. Tan et al. ORCID iD: 0000-0002-2522-4524; 
  27. Li et al. Journal of Infection 2020; 
  28. Gao et al. J Med Virol 2020 ; 
  29. Guan et al. N Engl J Med 2020; 
  30. Zhu et al. ORCID iD: 0000-0001-7718-9591; 
  31. Chen et al. Lancet 2020; 
  32. Cao et al. medRxiv preprint 2020; 
  33. Zhang et al. Scandinavian J Clin Lab In 2020; 
  34. Dong et al. Int J Med Sci 2020; 
  35. Stringer et al. Int J Epidemi 2021; 
  36. Liu et al. J Clin Virol 2020; 
  37. Chen et al. Ann Clin Microbiol Antimicrob 2020; 
  38. Herold et al. J Allergy Clin Immunol 2020; 
  39. Dickens et al. Clinical Infectious Diseases 2020; 
  40. De Nardo et al. Int J Infect Dis 2020; 
  41. Feldt et al. STAKOB 2020; 
  42. Chinese National Health Commission. 3. March 2020. Chinese COVID-19 Management Guidelines; 
  43. Chinese Center for Disease Control and Prevention. 20. Aug. 2020. Treatment Strategies to Prevent Mild to Severe Progression of COVID-19 Cases; 
  44. SIMEU. 12. March 2020. Covid-19 First Line Report PS/DEA management organisational structure as part of an epidemic or pre-epidemic outbreak; 
  45. Regional Council of Campania Directorate General for the Protection of Health. Feb. 2020. Operational guidelines identification/management of suspected and proven cases of suspected Coronavirus; 
  46. IFCC. 6. April 2020. Information Guide on COVID-19

 

A Leader In Rapid Point-of-care Diagnostics.

PRODUCT CATALOG
SOLUTIONS
CUSTOMER STORIES
VIEWPOINTS
CONTACT US
PRODUCT DOCUMENT SEARCH
PRODUCT DEMOS
INTEREST-BASED ADS

©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.